Literature DB >> 27913700

Clinical decision-making in functional and hyperkinetic movement disorders.

Sandra M A van der Salm1, Anne-Fleur van Rootselaar1, Daniëlle C Cath1, Rob J de Haan1, Johannes H T M Koelman1, Marina A J Tijssen2.   

Abstract

OBJECTIVE: Functional or psychogenic movement disorders (FMD) present a diagnostic challenge. To diagnose FMD, clinicians must have experience with signs typical of FMD and distinguishing features from other hyperkinetic disorders. The aim of this study was to clarify the decision-making process of expert clinicians while diagnosing FMD, myoclonus, and tics.
METHODS: Thirty-nine movement disorders experts rated 60 patients using a standardized web-based survey resembling clinical practice. It provided 5 steps of incremental information: (1) visual first impression of the patient, (2) medical history, (3) neurologic examination on video, (4) the Bereitschaftspotential (BP), and (5) psychiatric evaluation. After full evaluation of each case, experts were asked which diagnostic step was decisive. In addition, interim switches in diagnosis after each informational step were calculated.
RESULTS: After full evaluation, the experts annotated the first impression of the patients as decisive in 18.5% of cases. Medical history was considered decisive in 33.3% of cases. Neurologic examination was considered decisive in 39.7%, the BP in 8%, and the psychiatric interview in 0.5% of cases. Most diagnostic switches occurred after addition of the medical history (34.5%). Addition of the neurologic examination led to 13.8% of diagnostic switches. The BP results led to diagnostic switches in 7.2% of cases. Psychiatric evaluation resulted in the lowest number of diagnostic switches (2.7% of cases).
CONCLUSIONS: Experts predominantly rely on clinical assessment to diagnose FMD. Importantly, ancillary tests do not determine the final diagnosis of this expert panel. In general, the experts infrequently changed their differential diagnosis.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 27913700     DOI: 10.1212/WNL.0000000000003479

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Cerebral preparation of spontaneous movements: An EEG study.

Authors:  Elise Houdayer; Sae-Jin Lee; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-08-25       Impact factor: 3.708

Review 2.  Functional Movement Disorders and Placebo: A Brief Review of the Placebo Effect in Movement Disorders and Ethical Considerations for Placebo Therapy.

Authors:  Bonnie M Kaas; Casey Jo Humbyrd; Alexander Pantelyat
Journal:  Mov Disord Clin Pract       Date:  2018-10-09

3.  Clinical Characteristics of Functional Movement Disorders: A Clinic-based Study.

Authors:  Jung E Park
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-07-02

4.  Distinctive tics suppression network in Gilles de la Tourette syndrome distinguished from suppression of natural urges using multimodal imaging.

Authors:  Sandra M A van der Salm; Johan N van der Meer; Daniëlle C Cath; Paul F C Groot; Ysbrand D van der Werf; Eelke Brouwers; Stella J de Wit; Joris C Coppens; Aart J Nederveen; Anne-Fleur van Rootselaar; Marina A J Tijssen
Journal:  Neuroimage Clin       Date:  2018-09-19       Impact factor: 4.881

5.  Hiding in Plain Sight: Functional Neurological Disorders in the News.

Authors:  Stoyan Popkirov; Timothy R Nicholson; Bastiaan R Bloem; Hannah R Cock; Christopher P Derry; Roderick Duncan; Barbara A Dworetzky; Mark J Edwards; Alberto J Espay; Mark Hallett; Anthony E Lang; John Paul Leach; Alexander Lehn; Aileen McGonigal; Francesca Morgante; David L Perez; Markus Reuber; Mark P Richardson; Philip Smith; Maria Stamelou; Marina A J Tijssen; Michele Tinazzi; Alan J Carson; Jon Stone
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2019-05-23       Impact factor: 2.198

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.